Form 4: Cardinal Health CEO Sells Shares After RSU Vesting

Cardinal Health's CEO of GMPD Segment, Stephen M. Mason, reported the acquisition of restricted stock units and subsequent sales of common shares, including tax-related withholdings.

Summary

• Stephen M. Mason, CEO of GMPD Segment at Cardinal Health Inc. (CAH), reported transactions involving the company's common shares.
• Acquired 8,957 common shares on August 15, 2025, through a grant of restricted share units (RSUs) that are scheduled to vest in three equal annual installments beginning on August 15, 2026.
• Disposed of 30,811 common shares on August 15, 2025, at a price of $150.22 per share, to satisfy tax withholding obligations related to the vesting of 14,157 RSUs and 54,537 performance share units.
• Sold a total of 41,575 common shares on August 19, 2025, in multiple open market transactions.
• These sales occurred at weighted average prices of $147.87 (for 2,997 shares), $148.83 (for 34,411 shares), and $149.39 (for 4,167 shares).
• Following all reported transactions, beneficial ownership stands at 26,085 common shares.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to significant insider share sales by a key executive, even though some shares were acquired via RSU grant and some dispositions were for tax purposes. Open market sales by an insider can sometimes signal a lack of confidence or a desire to diversify, which is generally viewed unfavorably by the market.

Positives

• A grant of 8,957 restricted share units to the CEO indicates continued equity incentive and alignment with long-term company performance.

Negatives

• CEO Stephen M. Mason sold a total of 41,575 common shares in open market transactions, which reduces his direct equity stake in the company.
• The sales occurred at weighted average prices ranging from $147.87 to $149.39.

Future Outlook

NA

Industry Context

This Form 4 filing details routine insider transactions for a senior executive at a major healthcare services and products company. Such filings are common and reflect executive compensation practices and personal financial planning, rather than broader industry trends.

Related Party Transactions

• The filing details transactions by Stephen M. Mason, CEO of GMPD Segment, who is a related party to Cardinal Health Inc.
• Transactions include the grant of restricted share units, withholding of shares for tax obligations, and open market sales of common shares.

Stakeholder Impact

• Shareholders may interpret the executive's share sales as a potential signal regarding future company performance or executive confidence, which could influence investor sentiment.
• The RSU grant aligns executive incentives with long-term shareholder value, albeit partially offset by the share sales.

Next Steps

• The granted restricted share units will vest in three equal annual installments beginning August 15, 2026.

Key Dates

Recommendation

While the insider sales by a key executive could be perceived negatively, the transactions also include a grant of new restricted stock units, indicating continued long-term incentive alignment. The sales might be for personal financial planning or diversification. Without additional company-specific news or broader market context, a 'hold' recommendation is appropriate, advising investors to monitor future filings and company performance.

Keywords

Cardinal Health, CAH, SEC Form 4, Insider Trading, Stock Sales, Restricted Stock Units, Executive Compensation, Stephen M. Mason, Share Ownership